ORACLE CORP DEPOSITARY SH REP 1/2000TH PFD SER D

ORACLE CORP DEPOSITARY SH REP 1/2000TH PFD SER D released FY2025 9 Months earnings on March 11 (EST), actual revenue USD 41.5 B, actual EPS USD 0.525

KORE

EUREKA ACQUISITION CORP COM USD0.0001 A (SUBS/RTS 03/07/2026)

Ensysce Biosciences

Applied Optoelectronics

OneMedNet

INNEOVA

GraniteShares 2x Long DELL Daily ETF

Edesa Biotech

Chaince Digital

Avalon GloboCare

$Oracle(ORCL.US) Oracle poured with lawsuits and negative news all round makes me want to give up on it. Perhaps the toughest buy for me since I started investing but I&#39;ll take it as a lesson learnt, after all there&#39;s always wins and losses in life. @Bridge Buzz SG

Oracle

My biggest worry with $Oracle(ORCL.US) isn't the business - it's the class action lawsuits piling up over AI capex disclosures. Multiple firms now soliciting plaintiffs . Even if they settle for peanuts, legal distraction costs management time. Meanwhile Oppenheimer upgrades to $185. Trying to decide if this is noise or real risk.

$Oracle(ORCL.US) technicals: broke above $150 resistance today, now $152.30. 52-week range $118.86-$345.72, currently 56% below highs. RSI recovering from oversold, MACD bullish crossover forming. Oppenheimer upgrade catalyst. $185 PT implies 21% upside. Bottom fishing season? 🎣

The lawsuits are getting serious now. Multiple securities fraud class actions over AI spending disclosures . When lawyers circle like this, usually means someone messed up the messaging. But the business itself still solid? $Oracle(ORCL.US)

36 analysts, $Oracle(ORCL.US) range $155 to $400. Citizens cut to $285 from $342, Piper Sandler to $240 from $290, Morgan Stanley to $213 from $320 . Jefferies still at $400. Stock at $141. When analysts disagree this much, truth is in the middle. Middle is $277, 96% upside

I feel empathy to see your red signal cuz I also went through a hard time like this

rocket Shadow

$Oracle(ORCL.US)I’m at a loss now, but still bullish longer term. Cloud infrastructure and enterprise migration trends are strong secular drivers. Near term weakness could be sentiment-driven. If execution on OCI growth continues, I believe valuation can recover. Treating this as patience-required accumulation phase.

ORACLE CORP DEPOSITARY SH REP 1/2000TH PFD SER D(ORCL-D.US)